Dr. Hemant Kumar, Ph.D.
Associate Professor , Department of Pharmacology and Toxicology
-
National Institute of Pharmaceutical Education and Research-Ahmedabad -
hemant[at]niperahm[dot]res[dot]in, hemantbhave[at]gmail[dot]com, -
+91 79-65181200 -
Gandhinagar -
Gandhinagar, Gujarat, India - 382355
Research Interest
- In vivo pharmacology: spinal cord injury, demyelination, Parkinson’s disease, neuropathic and inflammatory pain
- Extracellular vesicles as the endogenous signalling system of the injured central nervous system: Rab27a-dependent release, cargo sorting and target selectivity
- Neuroimmunology and neurovascular biology: glial and fibrotic scarring, blood–spinal cord barrier integrity, TRPV4, CD36, angiopoietin-1, PDGFR-β
- Engineered nanotherapeutics: nanozyme–exosome hybrids, stem cell-derived nanovesicles, conductive scaffolds for neural repair
- Vesicle-based diagnostics: circulating signatures reporting injury severity, phase and outcome in neurotrauma
Experience
- Jan 2025 – present
Associate Professor
NIPER- Ahmedabad, Palaj, Gandhinagar
- January 2020 -Jan 2025
Assistant Professor
NIPER- Ahmedabad, Palaj, Gandhinagar
- September 2017 – January 2020
Assistant Professor
CHA University South Korea
- December 2015 – August 2017
Korean Research Fellow
CHA University, South Korea
- December 2009 – February 2011
Senior Research Biologist
Chembiotek (TCG Lifescience),Kolkata
- April 2009 – December 2009
Research officer
Glenmark Pharmaceuticals,Mumbai
- May 2007 – March 2009
Research Associate
Glenmark Pharmaceuticals, Mumbai
- June 2006 – March 2007
Research Trainee
CDRI,Lucknow
Research Grants
- SERB-ANRF, Government of India – Principal Investigator
- Industry-sponsored (Stempeutics Research Pvt. Ltd.) – Principal Investigator
- SERB-Start-up Research Grant – Principal Investigator
- Investigator-Initiated Research Proposals for Intermediate Extramural Grants (ICMR) – Co-Investigator
- Department of Biotechnology (DBT) – Co-Investigator
- SERB-Core Research Grant – Co-Investigator
- Investigator-Initiated Research Proposals for Small Extramural Grants (ICMR) – Co-Investigator
- Ministry of Science, ICT and Future Planning, National Research Foundation, South Korea – Principal Investigator
- Korea Research Fellowship (KRF) for doing post-doc
- KOR-EU research grant for visiting Ospedale San Raffaele
Patent
- Composition containing α-asarone for prevention or treatment of spinal cord injury.
Han I-B, Jo M-J, Choi H-M, Kumar H. Republic of Korea, KR 10-2019-0040409 (WO 2019/074235).
Granted - Nano-vesicle derived from adult stem cells and use thereof for targeted treatment.
Kim B-S, Kim H-Y, Han I-B, Kumar H. Republic of Korea, KR 10-2020-0128501 (WO 2019/151744).
Granted - Multifunctional Zn-Se-Mn nanozymes for reactive oxygen species scavenging and inflammation modulation.
Kumar H, Singh N, Benival D, Chopra M, Goyal D, Pathak Z, Singh A, Tripathi G.
India, 202621076098 (2026).
Filed - Polyheterocyclic imidazole derivatives, chemical entities thereof, and their pharmaceutical applications.
Amit Shard; Pinaki Sengupta; Kumar Hemant; Manjeet Chopra; Nasir Khan; Varun Rawat; Shailendra Sharma.
2026, India, 202621080184.
Filed - Composition for preventing or treating spinal cord injury, comprising a TRPV4 antagonist.
Han I-B, Kumar H. PCT, WO 2021/015342.
Published